Clinical Trial Update: Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing NN1250 plus insulin aspart to insulin detemir plus insulin aspart in Type 1 diabetes has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)
• Insulin detemir (insulin detemir)
• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-16